“Authors’ Reply – Comments: Serum Levels of Infliximab in Brazilian Patients With Crohn’s Disease: What Are the Reasons for Differences from Previous Studies?”. 2019. Clinics 74 (October): e1517. https://doi.org/10.6061/clinics/2019/e1517.